SALIX PHARMACEUTICALS LTD Supply Agreements
13 Contracts & Agreements
- AMENDMENT NUMBER FOUR TO SUPPLY AGREEMENT (Filed With SEC on October 17, 2014)
- AMENDMENT NUMBER THREE TO SUPPLY AGREEMENT (Filed With SEC on October 17, 2014)
- AMENDMENT NO. 8 TOMANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on August 8, 2014)
- MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on August 8, 2014)
- Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. THIRD AMENDMENT TO RIFAXIMIN MANUFACTURING AND SUPPLY AGREEMENT between SALIX... (Filed With SEC on August 9, 2013)
- Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. SECOND AMENDMENT TO RIFAXIMIN MANUFACTURING AND SUPPLY AGREEMENT between SALIX... (Filed With SEC on May 10, 2013)
- Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. AMENDMENT NUMBER TWO TO SUPPLY AGREEMENT (Filed With SEC on November 8, 2012)
- Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. EIR SUPPLY AGREEMENT dated August 6, 2012 by and between ALFA WASSERMANN S.P.A. and... (Filed With SEC on November 8, 2012)
- Portions of this exhibit marked [*] are omitted and are requested to be treatedconfidentially. MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on February 28, 2012)
- FINISHED PRODUCT MANUFACTURING AND SUPPLY AGREEMENT between SALIX PHARMACEUTICALS, INC. and LUPIN LTD. Dated as of 31 March 2011 TABLE OF CONTENTS (Filed With SEC on May 10, 2011)
- FIRST AMENDMENT TO RIFAXIMIN MANUFACTURING AND SUPPLY AGREEMENT between SALIX PHARMACEUTICALS, INC. and LUPIN LTD. Dated as of 31 March 2011 (Filed With SEC on May 10, 2011)
- Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. SUPPLY AND DISTRIBUTION AGREEMENT (Filed With SEC on March 14, 2008)
- Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. SUPPLY AGREEMENT (Filed With SEC on August 9, 2004)
